Algorithm for using clinical and laboratory features to help distinguish the nature of “big blue” cells in blood smears, i.e. to determine if they are reactive lymphocytes or part of hematopoietic neoplasia (large cell lymphoma, acute lymphoid leukemia or acute myeloid leukemia).